Am-is, Maria Fe C.
HRN: 24 47 43 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/31/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
01/31/2024
02/06/2024
IV
600mg
Q8
Septicemia
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes